focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

1 Jul 2010 07:00

RNS Number : 5970O
ViaLogy PLC
01 July 2010
 



 

VIALOGY PLC

BUSINESS UPDATE 

New prospects analyses delivered

Industry specialists join ViaLogy

 

Pasadena, July 1st, 2010. ViaLogy PLC (LSE: VIY) announces that it has this week delivered recommended well drilling locations, positioned using its proprietary QuantumRD technology, to two clients that plan to commence drilling on the sites in the coming weeks. Under the two contracts, ViaLogy's deliverables include multiple specified well sites and ViaLogy receives an overall service fee plus a working interest success fee for each completed well.

In addition, ViaLogy is now in advanced talks with prospective clients to apply QuantumRD for shale gas exploration and production. 

ViaLogy also announces two senior technical staff appointments that will augment current capacity to service it's increasing workflow and accelerate introduction of QuantumRD, to a broad set of exploration and production firms.

Dr. Robert Parney joins ViaLogy as Chief Geophysicist and Vice President, Geophysical Services. He brings over twenty years of experience as a reservoir geophysicist/geo-scientist, and is a recognized industry expert in all facets of seismic technology from acquisition and processing to interpretation and reservoir characterization. Over the last five years he has been extensively involved with major US shale gas plays, including Woodford, Marcellus, Haynesville and Baxter. His industry experience includes Asia, North and South America, Europe and the Middle East. He has extensive experience in both the analytical and reservoir engineering aspects of hydrocarbon exploration and field development, and brings to ViaLogy a wide range of contacts in the petroleum industry.

Previously, Dr Parney has worked with Tricon Geophysics and GX Technology, as well as publishing numerous articles on geophysics and hydrogeology. Dr. Parney received his Ph.D. from the University of British Columbia.

Dr. Andres Chavarria has been appointed as Senior Geophysicist, bringing over fifteen years of analytical and management experience in the seismic data processing area. Dr. Chavarria is an expert in structural imaging and borehole seismic analysis from 3D and multi-component surveys for both on shore and offshore fields. He has prior successes in the product development of state of the art imaging technologies, including magnetic and electromagnetic geophysical acquisition systems, and their adaptation and application to a range of reservoir development projects. Previously, Dr. Chavarria has worked at Conoco and Pemex, among others, and has experience in projects in the Americas, the Middle East, Europe, China and West Africa. Andres also brings extensive industry contacts, and, like Dr. Parney, has numerous technical publications to his credit, as well as extensive field work. He was awarded his Ph.D. from Duke University.

ViaLogy CEO, Robert Dean, said, "Both Bob and Andres were selected after extensive evaluation of a long list of candidates. They each have superior industry track records as innovative, hands-on professionals in the advanced use of seismic data across a range of formations - onshore, offshore, and shale gas. They will work closely with our Chief Technology Officer, Dr. Sandeep Gulati, to develop QuantumRD - our unique technology that exploits, as an information source, the 'noise' inherent in most seismic signal data - into a standard industry tool." 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734   

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner / Jeremy Stephenson, Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magnetotelluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDBGDLRDXBGGG
Date   Source Headline
11th Sep 20237:00 amRNSCancellation - Yourgene Health plc
11th Sep 20237:00 amRNSDe-listing and cancellation of trading of Shares
8th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
8th Sep 202311:23 amRNSScheme of Arrangement becomes Effective
8th Sep 20239:54 amRNSForm 8.5 (EPT/RI)
8th Sep 20237:30 amRNSSuspension - Yourgene Health Plc
7th Sep 202311:46 amRNSCourt sanction of the Scheme of Arrangement
7th Sep 202310:10 amRNSForm 8.5 (EPT/RI)
5th Sep 202310:30 amRNSForm 8.5 (EPT/RI)
4th Sep 202310:01 amRNSForm 8.5 (EPT/RI)
1st Sep 20235:30 pmRNSYourgene Health
1st Sep 202312:07 pmRNSForm 8.5 (EPT/RI)
31st Aug 202310:58 amRNSForm 8.3 - Yourgene Health PLC
31st Aug 20239:42 amRNSForm 8.5 (EPT/RI)
30th Aug 20239:42 amRNSForm 8.5 (EPT/RI)
24th Aug 20239:27 amRNSForm 8.5 (EPT/RI) - Yourgene Health PLC
23rd Aug 20239:50 amRNSForm 8.5 (EPT/RI)
23rd Aug 20239:24 amRNSForm 8.3 - Yourgene Health PLC
22nd Aug 20231:25 pmRNSHolding(s) in Company
22nd Aug 20239:01 amRNSForm 8.5 (EPT/RI)
21st Aug 20235:29 pmRNSForm 8.3 - Yourgene Health plc
21st Aug 20232:12 pmRNSForm 8.3 - Yourgene Health plc
21st Aug 202311:03 amRNSForm 8.5 (EPT/RI) - Yourgene Health PLC
21st Aug 20237:02 amRNSForm 8.3 - Yourgene Health PLC
18th Aug 20233:09 pmRNSForm 8.3 - Yourgene Health plc
18th Aug 20231:28 pmRNSForm 8.5 (EPT/RI)
17th Aug 20235:03 pmRNSResult of Court Meeting and General Meeting
17th Aug 202310:13 amRNSForm 8.5 (EPT/RI)
16th Aug 20239:40 amRNSForm 8.5 (EPT/RI)
15th Aug 20234:41 pmRNSForm 8.5 (EPT/RI) Replacement
15th Aug 202312:00 pmRNSForm 8.5 (EPT/RI)
14th Aug 202310:16 amRNSForm 8.5 (EPT/RI)
14th Aug 20239:20 amRNSForm 8.3 - Yourgene Health PLC
11th Aug 20231:12 pmRNSForm 8.3 - Yourgene Health plc
11th Aug 202310:10 amRNSForm 8.5 (EPT/RI)
10th Aug 202311:59 amRNSForm 8.5 (EPT/RI)
9th Aug 202310:12 amRNSForm 8.5 (EPT/RI)
8th Aug 20231:57 pmRNSForm 8.3 - Yourgene Health plc
8th Aug 202311:43 amRNSForm 8.5 (EPT/RI)
7th Aug 20231:57 pmRNSForm 8.3 - Yourgene Health plc
7th Aug 202311:56 amRNSForm 8.5 (EPT/RI)
4th Aug 20231:35 pmRNSForm 8.3 - Yourgene Health plc
4th Aug 202310:54 amRNSForm 8.5 (EPT/RI)
4th Aug 202310:47 amRNSForm 8.3 - Yourgene Health PLC
3rd Aug 202310:04 amRNSForm 8.5 (EPT/RI)
3rd Aug 20239:51 amRNSForm 8.3 - Yourgene Health PLC
3rd Aug 20239:19 amRNSForm 8.3 - YOURGENE HEALTH PLC
2nd Aug 20232:02 pmRNSForm 8.3 - Yourgene Health plc
2nd Aug 202310:21 amRNSForm 8.5 (EPT/RI)
1st Aug 20235:30 pmRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.